These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17762648)

  • 1. Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na/K-ATPase inhibitor.
    Fedorova OV; Zhuravin IA; Agalakova NI; Yamova LA; Talan MI; Lakatta EG; Bagrov AY
    J Hypertens; 2007 Sep; 25(9):1834-44. PubMed ID: 17762648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl-loaded Dahl-S rats.
    Fedorova OV; Agalakova NI; Talan MI; Lakatta EG; Bagrov AY
    J Hypertens; 2005 Aug; 23(8):1515-23. PubMed ID: 16003178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANP differentially modulates marinobufagenin-induced sodium pump inhibition in kidney and aorta.
    Fedorova OV; Agalakova NI; Morrell CH; Lakatta EG; Bagrov AY
    Hypertension; 2006 Dec; 48(6):1160-8. PubMed ID: 17043158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride--dependent hypertension.
    Fedorova OV; Talan MI; Agalakova NI; Lakatta EG; Bagrov AY
    Circulation; 2002 Mar; 105(9):1122-7. PubMed ID: 11877366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
    Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
    Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous cardiotonic steroids and differential patterns of sodium pump inhibition in NaCl-loaded salt-sensitive and normotensive rats.
    Bagrov AY; Agalakova NI; Kashkin VA; Fedorova OV
    Am J Hypertens; 2009 May; 22(5):559-63. PubMed ID: 19229192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous Na,K pump ligands are differentially regulated during acute NaCl loading of Dahl rats.
    Fedorova OV; Lakatta EG; Bagrov AY
    Circulation; 2000 Dec; 102(24):3009-14. PubMed ID: 11113054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
    Bagrov AY; Fedorova OV
    J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms.
    Fedorova OV; Bagrov AY
    Am J Hypertens; 1997 Aug; 10(8):929-35. PubMed ID: 9270089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of two endogenous Na+,K(+)-ATPase inhibitors, marinobufagenin and ouabain, on isolated rat aorta.
    Bagrov AY; Roukoyatkina NI; Pinaev AG; Dmitrieva RI; Fedorova OV
    Eur J Pharmacol; 1995 Feb; 274(1-3):151-8. PubMed ID: 7768267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous cardiac glycosides: hormones using the sodium pump as signal transducer.
    Schoner W; Scheiner-Bobis G
    Semin Nephrol; 2005 Sep; 25(5):343-51. PubMed ID: 16139690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension.
    Fedorova OV; Simbirtsev AS; Kolodkin NI; Kotov AY; Agalakova NI; Kashkin VA; Tapilskaya NI; Bzhelyansky A; Reznik VA; Frolova EV; Nikitina ER; Budny GV; Longo DL; Lakatta EG; Bagrov AY
    J Hypertens; 2008 Dec; 26(12):2414-25. PubMed ID: 19008721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose cardiotonic steroids increase sodium-potassium ATPase activity that protects hippocampal slice cultures from experimental ischemia.
    Oselkin M; Tian D; Bergold PJ
    Neurosci Lett; 2010 Apr; 473(2):67-71. PubMed ID: 19822191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of ouabain and marinobufagenin leads to different structural changes in Na,K-ATPase and depends on the enzyme conformation.
    Klimanova EA; Petrushanko IY; Mitkevich VA; Anashkina AA; Orlov SN; Makarov AA; Lopina OD
    FEBS Lett; 2015 Sep; 589(19 Pt B):2668-74. PubMed ID: 26297827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma marinobufagenin-like and ouabain-like immunoreactivity during saline volume expansion in anesthetized dogs.
    Bagrov AY; Fedorova OV; Dmitrieva RI; French AW; Anderson DE
    Cardiovasc Res; 1996 Feb; 31(2):296-305. PubMed ID: 8730407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardenolide and bufadienolide ligands of the sodium pump. How they work together in NaCl sensitive hypertension.
    Bagrov AY; Fedorova OV
    Front Biosci; 2005 Sep; 10():2250-6. PubMed ID: 15970491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of an Endogenous Steroidal Na Pump Inhibitor Marinobufagenin, Implicated in Human Cardiovascular Diseases, Is Initiated by CYP27A1 via Bile Acid Pathway.
    Fedorova OV; Zernetkina VI; Shilova VY; Grigorova YN; Juhasz O; Wei W; Marshall CA; Lakatta EG; Bagrov AY
    Circ Cardiovasc Genet; 2015 Oct; 8(5):736-45. PubMed ID: 26374826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of Na+-K+ ATPase activity on blood pressure regulation and sodium metabolism in DOCA-treated rats].
    Shigetomi S; Tosaki H; Ueno S; Kohno H; Mori K; Katoh K; Tanaka K; Haga H; Kin S; Matsunaga A
    Nihon Naibunpi Gakkai Zasshi; 1989 Oct; 65(10):1198-207. PubMed ID: 2556303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ouabain- and marinobufagenin-induced proliferation of human umbilical vein smooth muscle cells and a rat vascular smooth muscle cell line, A7r5.
    Abramowitz J; Dai C; Hirschi KK; Dmitrieva RI; Doris PA; Liu L; Allen JC
    Circulation; 2003 Dec; 108(24):3048-53. PubMed ID: 14638550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous sodium pump inhibitors and age-associated increases in salt sensitivity of blood pressure in normotensives.
    Anderson DE; Fedorova OV; Morrell CH; Longo DL; Kashkin VA; Metzler JD; Bagrov AY; Lakatta EG
    Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1248-54. PubMed ID: 18287222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.